MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$222,584K
Net loss
-$218,960K
Foreign currency
translation adjustment
-$3,624K
Interest and other income
$28,463K
Net loss before
income tax provision
-$218,808K
Provision for (benefit
from) income taxes
$152K
Total other income,
net
$28,257K
Novartis Collaboration
Agreement
$46,985K
Genentech
$14,681K
Bayer
$8,920K
Ionis Collaboration
Agreement
$2,000K
Interest expense
$206K
Loss from operations
-$247,065K
Collaboration revenue
$72,586K
Total operating
expenses
$319,651K
Research and development
$240,283K
General and
administrative
$79,368K
Back
Back
Income Statement
source: myfinsight.com
BICYCLE THERAPEUTICS PLC (BCYC)
BICYCLE THERAPEUTICS PLC (BCYC)